NCT06559579View on ClinicalTrials.gov

Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik)

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Gammopathy, Monoclonal
Trial Locations (2)

29609

CHU de Brest, Brest

Unknown

CHIC de Quimper, Quimper

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT06559579 - Monoclonal Gammopathy With Clinical Significance in Patients With and Without Haematological Malignancies in Finistère Between 2012 and 2017 (GammaClinik) | Biotech Hunter | Biotech Hunter